These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 28566551)
1. Outcome measures in the idiopathic inflammatory myopathies: On the search for the holy grail. Dimachkie MM; Paganoni S Neurology; 2017 Jul; 89(1):20-21. PubMed ID: 28566551 [No Abstract] [Full Text] [Related]
2. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Hoogendijk JE; Amato AA; Lecky BR; Choy EH; Lundberg IE; Rose MR; Vencovsky J; de Visser M; Hughes RA Neuromuscul Disord; 2004 May; 14(5):337-45. PubMed ID: 15099594 [No Abstract] [Full Text] [Related]
6. Novel insights of disability assessment in adult myositis. Espinosa-Ortega HF; Moreno-Ramirez M; Alexanderson H Curr Opin Rheumatol; 2017 Nov; 29(6):591-597. PubMed ID: 28796006 [TBL] [Abstract][Full Text] [Related]
7. [Inflammatory muscle diseases: dermatomyositis, polymyositis, and inclusion body myositis]. Genth E Internist (Berl); 2005 Nov; 46(11):1218-32. PubMed ID: 16200404 [TBL] [Abstract][Full Text] [Related]
8. 213th ENMC International Workshop: Outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18-20 September 2015. Benveniste O; Rider LG; Neuromuscul Disord; 2016 Aug; 26(8):523-34. PubMed ID: 27312023 [No Abstract] [Full Text] [Related]
9. TDP-43 plasma levels do not differentiate sporadic inclusion body myositis from other inflammatory myopathies. Kuiperij HB; Abdo WF; van Engelen BG; Schelhaas HJ; Verbeek MM Acta Neuropathol; 2010 Dec; 120(6):825-6. PubMed ID: 21046407 [No Abstract] [Full Text] [Related]
10. Misunderstandings, misperceptions, and mistakes in the management of the inflammatory myopathies. Kissel JT Semin Neurol; 2002 Mar; 22(1):41-51. PubMed ID: 12170392 [TBL] [Abstract][Full Text] [Related]
13. Clinical Evaluation and Management of Inflammatory Myopathies. Chhibber S; Amato AA Semin Neurol; 2015 Aug; 35(4):347-59. PubMed ID: 26502759 [TBL] [Abstract][Full Text] [Related]
14. [Diagnostics and therapy of myositis]. Müller-Felber W Fortschr Neurol Psychiatr; 2003 Oct; 71(10):549-62. PubMed ID: 14551856 [No Abstract] [Full Text] [Related]
15. Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations. Ernste FC; Reed AM Mayo Clin Proc; 2013 Jan; 88(1):83-105. PubMed ID: 23274022 [TBL] [Abstract][Full Text] [Related]
16. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy. Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697 [TBL] [Abstract][Full Text] [Related]
17. Sporadic inclusion body myositis: A review of recent clinical advances and current approaches to diagnosis and treatment. Needham M; Mastaglia FL Clin Neurophysiol; 2016 Mar; 127(3):1764-73. PubMed ID: 26778717 [TBL] [Abstract][Full Text] [Related]
19. A comparison of inflammatory myopathies at whole-body turbo STIR MRI. Cantwell C; Ryan M; O'Connell M; Cunningham P; Brennan D; Costigan D; Lynch T; Eustace S Clin Radiol; 2005 Feb; 60(2):261-7. PubMed ID: 15664582 [No Abstract] [Full Text] [Related]
20. International Workshop on Inclusion Body Myositis held at the Institute of Myology, Paris, on 29 May 2009. Benveniste O; Hilton-Jones D Neuromuscul Disord; 2010 Jun; 20(6):414-21. PubMed ID: 20413309 [No Abstract] [Full Text] [Related] [Next] [New Search]